Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic useInitial U.S. Approval: 1998
Medication labelWhy this: Advisory · dailymed-prescription
AZOPT is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure (IOP) in patients with ocular hypertension or open-angle glaucoma.
- generic_name
- brinzolamide
- product_names
- brinzolamide
- ndc
- 66758-085, 66758-085-70, 66758-085-85
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en